http://www.unboundmedicine.com/medline/ebm/research/ThiazolidinedionesUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19046129/full_citation/Emerging_dipeptidyl_peptidase_4_inhibitors_for_the_treatment_of_diabetes_Ahrén B 
Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes. [Journal Article]
Expert Opin Emerg Drugs 2008 Dec; 13(4):593-607.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19041764/full_citation/Vascular_PPARgamma_Controls_Circadian_Variation_in_Blood_Pressure_and_Heart_Rate_through_Bmal1_Wang N, Yang G, Jia Z, et al. 
Vascular PPARgamma Controls Circadian Variation in Blood Pressure and Heart Rate through Bmal1. [Journal Article]
Cell Metab 2008 Dec; 8(6):482-91.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19037881/full_citation/Role_of_PPARgamma_in_renoprotection_in_Type_2_diabetes:_molecular_mechanisms_and_therapeutic_potential_Yang J, Zhang D, Li J, et al. 
Role of PPARgamma in renoprotection in Type 2 diabetes: molecular mechanisms and therapeutic potential. [Journal Article]
Clin Sci (Lond) 2009 Jan; 116(1):17-26.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19037880/full_citation/Cellular_and_molecular_effects_of_n_3_polyunsaturated_fatty_acids_on_adipose_tissue_biology_and_metabolism_Flachs P, Rossmeisl M, Bryhn M, et al. 
Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. [Journal Article]
Clin Sci (Lond) 2009 Jan; 116(1):1-16.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19035881/full_citation/Liver_X_Receptors__LXR__as_Therapeutic_Targets_in_Dyslipidemia_Bełtowski J 
Liver X Receptors (LXR) as Therapeutic Targets in Dyslipidemia. [JOURNAL ARTICLE]
Cardiovasc Ther 2008 Dec; 26(4):297-316.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19034866/full_citation/Cardiovascular_risk_and_cardiometabolic_protection:_role_of_glitazones_Petrazzi L, Grassi D, Polidoro L, et al. 
Cardiovascular risk and cardiometabolic protection: role of glitazones. [Journal Article]
J Nephrol 2008 Nov-Dec; 21(6):826-35.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19026177/full_citation/Management_of_type_2_diabetes_in_patients_with_heart_failure_Aguilar D 
Management of type 2 diabetes in patients with heart failure. [Journal Article]
Curr Treat Options Cardiovasc Med 2008 Dec; 10(6):465-75.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19008007/full_citation/Rosiglitazone_preserves_islet_beta_cell_function_of_adult_onset_latent_autoimmune_diabetes_in_3_years_follow_up_study_Yang Z, Zhou Z, Li X, et al. 
Rosiglitazone preserves islet beta-cell function of adult-onset latent autoimmune diabetes in 3 years follow-up study. [JOURNAL ARTICLE]
Diabetes Res Clin Pract 2008 Nov 11.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19002105/full_citation/PPAR_gamma_agonist_attenuates_renal_interstitial_fibrosis_and_inflammation_through_reduction_of_TGF_beta_Kawai T, Masaki T, Doi S, et al. 
PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta. [JOURNAL ARTICLE]
Lab Invest 2008 Nov 10.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18996102/full_citation/Physiogenomic_comparison_of_edema_and_BMI_in_patients_receiving_rosiglitazone_or_pioglitazone_Ruaño G, Bernene J, Windemuth A, et al. 
Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazone. [JOURNAL ARTICLE]
Clin Chim Acta 2008 Oct 26.
Abstract | Full Citation